期刊文献+

美洛昔康对骨科术后的镇痛疗效及其安全性评价 被引量:8

Efficacy and safety evaluation of meloxicam for orthopedic patients with postoperative analgesia
下载PDF
导出
摘要 目的探讨美洛昔康对骨科术后的阵痛疗效及其安全性。方法随机选择2011年1月至2012年5月来我院就诊的78例骨科手术患者,所有患者均在术后1 h、24 h肌注15 mg美洛昔康进行镇痛,对镇痛疗效不理想者给予芬太尼注射液进行补充镇痛。评估患者疼痛程度,记录患者术前和术后1周血常规、肝肾功能的变化情况,观察治疗时有无药物相关的不良事件发生。结果患者大手术、中手术、小手术用药前(术后1 h)VAS评分分别为9.2、8.1、7.9,用药后各时间点与基线VAS评分比较有明显下降(P<0.05),使用美洛昔康术后镇痛整体疗效满意;各组疼痛缓解率结果显示,美洛昔康对不同类型手术均有良好的镇痛效果;小型手术患者使用美洛昔康的镇痛效果优于大、中手术患者(P<0.05)。所有患者在术后拔出安置的引流管时,未发生引流量增多等异常现象;治疗期间患者未发生手术切口严重出血、胃痛、胃溃疡、恶心呕吐等与美洛昔康相关的不良反应;未发生心律失常、心肌梗死等不良反应。结论美洛昔康可有效缓解骨科术后疼痛,无明显不良反应,临床用药安全,是有效的骨科术后镇痛药。 Objective To explore the efficacy and safety of meloxicam on orthopedics postoperative analgesi-a. Methods 78 patients with ulcerative colitis in our hospital from January 2011 to May 2012 were chosen,and all the patients were respectively injected with 15 mg meloxicam for analgesia at 1 h and 24 h after operation. Fentanyl analge-sia was added to the patients with incompletely analgesic. The extent of pain was assessed,and the change of blood rou-tine examination,liver and kidney function were recorded before and at 1 week after operation. The drug-related adverse events was observed. Results The VAS scores of patients with major surgery,moderate surgery and minor surgery be-fore treatment (1 h after surgery) were 9. 2,8. 1,7. 9;and the VAS score decreased significantly after medication (P〈0. 05). The postoperative analgesia effect was satisfactory after using meloxicam. The analgesic effect of meloxicam on different types of operation were good. The analgesic effect of meloxicam in patients with minor surgery was better than those with major surgery and moderate surgery ( P &lt;0. 05 ) . No abnormal phenomenon flow increase was observed when drainage tube was drawn out. During treatment,no severe bleeding in surgical incision,stomach pain,stomach ul-cers,nausea,vomit was observed. There was no arrhythmia,myocardial infarction and other adverse events. Conclusion Meloxicam can effectively relieve orthopedic postoperative pain without obvious adverse reaction,it is an effective orthopedic postoperative analgesics with good safety.
出处 《实用药物与临床》 CAS 2014年第4期448-450,共3页 Practical Pharmacy and Clinical Remedies
关键词 美洛昔康 骨科手术 镇痛 安全性 Meloxicam Orthopedics surgery Analgesia Safety evaluation
  • 相关文献

参考文献11

二级参考文献53

共引文献51

同被引文献54

  • 1温艳珍,魏文珑,高志伟.美洛昔康的合成[J].中国医药工业杂志,2005,36(6):321-322. 被引量:1
  • 2贾宝秀,曹明亮,李珂,齐永秀,郝立勇,许成功.HPLC法测定美洛昔康胶囊的含量[J].泰山医学院学报,2006,27(2):97-98. 被引量:5
  • 3Apfelbaum JL,Desjardins PJ,Brown MT,et al.Multiple-rlay efficacy of parecoxib sodiurn treatment in postoperative hunioneo-tomy pain.Clin J Pain,2005,24(9):784-792.
  • 4李彦,李贺娟,邓斯斯.犬髋关节发育不良的临床调査[A].中国畜牧兽医学会2010年学术年会——第二届中国兽医临床大会论文集(下册)[C]. 2010.
  • 5徐建.美洛昔康治疗骨关节炎临床疗效[J].药物与临床,2014,2:243 -244.
  • 6Freedom of information summary new animal drug applicationnada 141 - 219. Metacam ( meloxicam) 5mg/mL Solution for In-jection [ Z] ?.
  • 7Karen L. Stasiak, Don Maul, Elisa French, et al. Species - Spe-cific Assessment of Pain in Laboratory Animals[ J]. The AmericanAssociation for Laboratory Animal Science,2003 ,42(4) : 13 -20.
  • 8Guideline for the conduct of efficacy studies for non - steroidal an-ti -inflammatory drugs. EMA/CVMP/EWP/1061/2001 - CON-SULTATION. 8 November 2012[S].
  • 9GFI - 123 development of target animal safety and effectivenessdata to support approval of nonsteroidal anti - inflammatory drugs(nsaids) for use in animals[ Z].
  • 10李晓玲,周宇,闫素英,王育琴.100例术后镇痛药物使用分析[J].药物流行病学杂志,2010,19(1):36-38. 被引量:2

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部